Loading insider details...
Beta
Latest Form 4 (Jun 26, 2026): Grant/Award of 15,527 ARVN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | ARVINAS, INC. (ARVN) | Grant/Award | 15,527 | n/a |
| Jun 9, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Mar 9, 2026 | ARVINAS, INC. (ARVN) | Purchase | 20,000 | $268.1K |
| Sep 24, 2025 | ARVINAS, INC. (ARVN) | Purchase | 30,000 | $227.0K |
| Jun 28, 2025 | ARVINAS, INC. (ARVN) | Grant/Award | 16,025 | n/a |
| Jun 13, 2025 | Werewolf Therapeutics, Inc. (HOWL) | Grant/Award | 27,000 | n/a |
| Jun 6, 2025 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |
| Jun 27, 2024 | Carisma Therapeutics Inc. (CARM) | Grant/Award | 19,350 | n/a |
| Jun 20, 2024 | Repare Therapeutics Inc. (RPTX) | Grant/Award | 27,200 | n/a |
| May 31, 2024 | ARVINAS, INC. (ARVN) | Grant/Award | 5,899 | n/a |